$147.79−1.06 (−0.71%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Revvity (RVTY) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~−7.1%/yr (FY21→FY25), net margin 8.4%, and free cash flow (~$509.4M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Returns vs FCF (168%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲3.7%
2,856.1
FY21→FY25CAGR −7.1%/yr
Net income ($M)▼10.8%
241.2
one-off year: see footnoteCAGR −28.9%/yr
Free cash flow ($M)▼6.0%
509.4
FY21→FY25CAGR −21.3%/yr
Diluted EPS▼5.9%
2.07
buyback-liftedCAGR −28.9%/yr
What the receipts whisper · what a headline number hides
Share count
−55.7%
252.4mn → 111.8mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$73.5M
−15.1% YoY in FY25 · 2.6% of revenue.
Returns vs FCF
168%
$853.6M returned vs $509.4M of FCF in FY25. The gap comes off the balance sheet (see net cash).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
8¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 63.6% → 54.8%. Net margin 8.4% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,941.8 | 2,856.1 | 2,755.0 | 2,750.6 | 3,311.8 | 3,827.8 | ▲3.7% | −7.1% |
Cost of revenue | 1,297.0 | 1,291.7 | 1,217.4 | 1,210.9 | 1,322.0 | 1,393.8 | ▲6.1% | −1.9% |
Gross profit | 1,644.8 | 1,564.4 | 1,537.7 | 1,539.7 | 1,989.8 | 2,434.0 | ▲1.7% | −10.5% |
Research & development | 213.1 | 215.8 | 196.8 | 216.6 | 221.6 | 200.3 | ▲9.7% | +1.9% |
Selling, general & admin | 1,059.5 | 991.9 | 994.1 | 1,022.6 | 1,025.5 | 975.2 | ▼0.2% | +0.4% |
Total operating expenses | 1,272.7 | 1,207.7 | 1,190.9 | 1,239.1 | 1,247.1 | 1,175.5 | ▲1.4% | +0.7% |
Operating incomefeeds ROC rank | 372.1 | 356.6 | 346.7 | 300.6 | 742.7 | 1,258.5 | ▲2.9% | −27.0% |
Other income, net | −89.3 | −88.4 | −30.6 | −117.6 | −90.9 | −54.9 | — | — |
Pretax income | 282.8 | 268.3 | 316.1 | 183.0 | 651.8 | 1,203.6 | ▼15.1% | −31.3% |
Income tax | 30.0 | 28.4 | 33.1 | 3.5 | 139.2 | 314.1 | ▼14.1% | −45.2% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 253.2 | 241.2 | 270.4 | 693.1 | 569.2 | 943.2 | ▼10.8% | −28.9% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 2.25 | 2.07 | 2.20 | 5.55 | 4.50 | 8.08 | ▼5.9% | −28.9% |
Diluted shares (mn) | 111.83 | 111.80 | 120.19 | 123.53 | 126.41 | 252.37 | ▼7.0% | −18.4% |
| Margins | ||||||||
Gross margin37th pct in Healthcare | 55.9% | 54.8% | 55.8% | 56.0% | 60.1% | 63.6% | ▼1.0pp | −8.8pp |
Operating margin | 12.6% | 12.5% | 12.6% | 10.9% | 22.4% | 32.9% | ▼0.1pp | −20.4pp |
Net margin64th pct in Healthcare | 8.6% | 8.4% | 9.8% | 25.2% | 17.2% | 24.6% | ▼1.4pp | −16.2pp |
† TTM = trailing four quarters through 2026-10-04.FY21 effective tax rate was 26% vs a 11% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was 21% vs a 11% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 13 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Revvity's revenue last fiscal year?
Revvity reported revenue of $2,856.1M in fiscal 2025, up 3.7% from fiscal 2024.
What was Revvity's net income?
Revvity reported net income of $241.2M in fiscal 2025, a net margin of 8.4%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

